ESC Congress Paris 2019
ATXA Therapeutics and PAH-Hope team members, Prof. Therese Kinsella & Dr. Helen Reid are looking forward to the ESC Congress 2019 next...
Experimental and Molecular Pathology
Use the link below to read or download ATXA Therapeutics published article on the expression and regulation of thromboxane receptors in...
New paper on thromboxane receptors in prostate inflammation published in Experimental and Molecular
ATXA Therapeutics, along with members of the academic research group of CSO Prof. Therese Kinsella at University College Dublin, have...
EIC Welcomes Entrepreneurs
PAH-HOPE CSO Prof. Therese Kinsella is in Brussels meeting fellow entrepreneurs in the EIC community at SME Phase 2 Coordinators Welcome...
Funding Opportunities for Breakthrough Innovation
ATXA Therapeutics Founder and CSO, Prof Therese Kinsella will represent the company at an event on the European Innovation Council...
Irish life sciences start-ups to watch
ATXA Therapeutics Ltd is proud to be listed among the 10 interesting Irish life sciences start-ups to watch. New hope for the PAH...
Keeping up with the competition
ATXA Therapeutics Ltd CEO Dr Ivan Coulter on keeping up with the competition in the pharma space as featured in today's Leaders' Insight...
Innovation Summit
The ATXA Therapeutics team is looking forward to attending the MedTech Strategist Innovation Summit Dublin 2019. 1 more day to go ! This...
ATXA attends BioCapital Europe
ATXA Therapeutics is attending BioCapital Europe in Amterdam today. #Lifesciences #investment
